The effect of glucose infusion on survival after acute mesenteric ischemia/reperfusion.
Perfusion of ischemic tissue with glucose has been shown to be deleterious to heart, spinal cord, and kidney. Observations that glucagon improves survival after acute mesenteric ischemia, however, suggest that hyperglycemia may not be deleterious during bowel ischemia. This experiment examined the effect of glucose infusion on survival in an established rat model of acute mesenteric ischemia. The superior (cranial) mesenteric artery (SMA) was occluded for 85 min in 36 anesthetized Sprague-Dawley rats. Animals were randomized to receive 5% glucose in normal saline (n = 15; 16.5 mL/kg.min iv), normal saline alone (n = 13; 16.4 mL/kg.min iv), or no intravenous fluid (n = 8). Ninety-minute intravenous infusions were initiated 10 min after SMA occlusion. Survival to 48 h was 47% in glucose-saline-treated rats, 31% in saline-only-treated rats, and 12.5% in control rats. These results demonstrate no deleterious effect of glucose infusion on mortality after acute mesenteric ischemia in this model.
Gerstle
J T
JT
Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Hanover, NH 03756.
Bech
F R
FR
Walsh
D B
DB
Cronenwett
J L
JL
D000818:Animals; D005947:Glucose / Q000008:administration & dosage* / Q000378:metabolism; D007262:Infusions, Intravenous; D007511:Ischemia / Q000188:drug therapy* / Q000378:metabolism; D008297:Male; D008638:Mesenteric Arteries; D051381:Rats; D011919:Rats, Inbred Strains; D015427:Reperfusion Injury / Q000188:drug therapy* / Q000378:metabolism
D005947:Glucose